Cart
Home / Moringa Oil / Evidence
Moringa Oil
The evidence

Moringa Oil

Early evidence   Single-origin, GC/MS tested, CoA in every box.

ModerateControlled human trialsRepeated studies in people.
EarlySmall / lab / animalPromising, not yet proven in people.
TraditionalLong-usedClinical evidence still anecdotal.
NoneNo trials foundWe looked and found none.
Key takeaways · last updated 2026-09-13

Moringa Oil carries an overall Early grade across the 12 studies linked on this page; the strongest signal is for acne.

  • Acne — Early evidence. A single narrative review mentions Moringa oleifera's anti-acne potential among many other dermatological uses, but this is based on compiling traditional uses and general phytochemical/pharmacological properties rather than clinical trials specifically testing Moringa for acne. PubMed 38055069
  • Aging/Wrinkles — Early evidence. The only clearly relevant study found is an animal experiment showing Moringa oleifera seed powder improved age-related vascular endothelial dysfunction in rats, which relates to systemic vascular aging rather than skin aging/wrinkles; no human or dermatological studies were identified. PubMed 31214278
  • Burns/Wound Healing — Early evidence. The main identified study shows Moringa oleifera leaf extract improved wound contraction, reduced epithelization time, and increased antioxidant enzyme activity and VEGF/TGF-β1 expression in an infected excision wound rat model, but this is a single animal study without human clinical trials. PubMed 35889362

What the studies say

Acne

Early

A single narrative review mentions Moringa oleifera's anti-acne potential among many other dermatological uses, but this is based on compiling traditional uses and general phytochemical/pharmacological properties rather than clinical trials specifically testing Moringa for acne.

“Exploring the potential of Moringa oleifera Lam in skin disorders and cosmetics: nutritional analysis, phytochemistry, geographical distribution, ethnomedicinal uses, dermatological studies and cosmetic formulations”

Read the study on PubMed →

Aging/Wrinkles

Early

The only clearly relevant study found is an animal experiment showing Moringa oleifera seed powder improved age-related vascular endothelial dysfunction in rats, which relates to systemic vascular aging rather than skin aging/wrinkles; no human or dermatological studies were identified.

“Moringa oleifera Seeds Improve Aging-Related Endothelial Dysfunction in Wistar Rats”

Read the study on PubMed →

Burns/Wound Healing

Early

The main identified study shows Moringa oleifera leaf extract improved wound contraction, reduced epithelization time, and increased antioxidant enzyme activity and VEGF/TGF-β1 expression in an infected excision wound rat model, but this is a single animal study without human clinical trials.

“Effect of Moringa oleifera Leaf Extract on Excision Wound Infections in Rats: Antioxidant, Antimicrobial, and Gene Expression Analysis”

Read the study on PubMed →

Dry Skin

Early

A narrative review notes moringa is marketed for moisturizing/antioxidant skincare benefits but lacks standardized formulation and clinical trial data, while a lab-based formulation study demonstrated antimicrobial and anti-inflammatory activity of a moringa seed oil cream without testing on human dry skin.

“Topical Moringa Formulations: An Emerging Skincare Ingredient”

Read the study on PubMed →

Eczema

Early

A single animal study found that a Moringa oleifera seed extract-loaded microemulsion hydrogel reduced atopic dermatitis-like symptoms, IgE levels, and inflammatory cytokines in a DNCB-induced mouse model, but no human clinical trials exist for eczema.

“Exploring the potential of Moringa oleifera seed extract-loaded microemulsion hydrogel in the DNCB-induced atopic dermatitis model”

Read the study on PubMed →

Fungal Infection

Early

Evidence for Moringa oleifera against fungal infection is limited to in-vitro studies, such as one showing antifungal activity of a leaf extract and derived bismuth nanoparticles against Candida and Aspergillus species; no clinical trials in humans were found.

“Use of A Hydroalcoholic Extract of Moringa oleifera Leaves for the Green Synthesis of Bismuth Nanoparticles and Evaluation of Their Anti-Microbial and Antioxidant Activities”

Read the study on PubMed →

Hyperpigmentation

Early

Only in-vitro/in-silico evidence exists showing Moringa oleifera leaf extract (via rutin) inhibits mushroom tyrosinase comparably to kojic acid, suggesting potential anti-pigmentation activity; no human or animal studies have tested Moringa for hyperpigmentation.

“Rutin of Moringa oleifera as a potential inhibitor to Agaricus bisporus tyrosinase as revealed from the molecular dynamics of inhibition”

Read the study on PubMed →

Joint Inflammation

Early

Available evidence consists mainly of a narrative review discussing Moringa oleifera's general anti-inflammatory and immunomodulatory properties, including brief mention of rheumatoid arthritis, but no dedicated clinical trials on joint inflammation were found in these results.

“Moringa oleifera Lam and its Therapeutic Effects in Immune Disorders”

Read the study on PubMed →

Muscle Pain

Early

Evidence is limited to animal (mouse) models of neuropathic pain and in-vitro/isolated compound studies showing antinociceptive and anti-inflammatory activity of Moringa oleifera extracts and root-derived compounds; no human clinical trials for muscle pain were found.

“Analgesic efficacy and subacute toxicity of Moroccan Aqueous Moringa oleifera leaf extract in a chronic constriction injury mouse model of neuropathic pain”

Read the study on PubMed →

Psoriasis

Early

One preclinical study identified three Moringa oleifera seed compounds (niazirin, marumoside A, sitosterol-3-O-β-d-glucoside) that suppressed Th17-related cytokines in vitro and ameliorated TPA-induced psoriasis-like skin lesions in mice, but no human clinical trials exist.

“Three Constituents of Moringa oleifera Seeds Regulate Expression of Th17-Relevant Cytokines and Ameliorate TPA-Induced Psoriasis-Like Skin Lesions in Mice”

Read the study on PubMed →

Rash/Contact Dermatitis

Early

Only one narrative review was identified, mentioning Moringa oleifera's immune-modulatory effects and potential benefit for atopic dermatitis and irritant-induced immune responses, but no clinical trials specifically testing Moringa for rash or contact dermatitis were found.

“Moringa oleifera Lam and its Therapeutic Effects in Immune Disorders”

Read the study on PubMed →

Sleep/Insomnia

Early

Only animal studies exist: Moringa oleifera seed oil enhanced pentobarbital-induced sleep in mice via GABAergic mechanisms, and leaf extract showed CNS depressant effects in mice, but no human clinical trials on sleep/insomnia were found.

“Moringa oleifera Lam Seed Oil Augments Pentobarbital-Induced Sleeping Behaviors in Mice via GABAergic Systems”

Read the study on PubMed →

Study counts reflect our internal research database. Figures are honest tallies, not marketing claims; every linked study opens on PubMed.